NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 807.00
+10.40 (1.31%)
Nov 6, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 158.31 billion as of November 6, 2026. It is the 7,272nd most valuable company in the world and the 433rd biggest in India. Its market cap has increased by 7.81% in one year.
Market Cap
158.31B
Enterprise Value
144.16B
Revenue
34.85B
Global Rank
Country Rank
#433 India
PE Ratio
12.63
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 158.31B, an increase of 36,768.13%. That is a compound annual growth rate of 23.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 158.31B | -2.13% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 323.31B |
| Piramal Pharma | 317.20B |
| Alivus Life Sciences | 183.81B |
| Alembic Pharmaceuticals | 175.63B |
| Cohance Lifesciences | 171.79B |
| Eris Lifesciences | 170.63B |
| Sudeep Pharma | 134.44B |
| Akums Drugs and Pharmaceuticals | 114.00B |